With a single exposure, Reveal™ delivers multiple diagnostic images, differentiating bone and soft tissue without motion artifacts.
Using KA Imaging’s patented technology, this detector goes beyond traditional Dual-Energy systems that require two exposures. At the same time, Reveal™ maintains low radiation exposure to the veterinary radiologist and the animal being imaged.
– FDA 510(k) cleared
– Health Canada approved
The advanced differentiation of bone and tissue in diagnostic imaging allows for better visualization of cartilage calcification and tiny kidney stones, among other applications.
Reveal is the world’s first portable dual-energy detector, and can be taken in the field.
Whereas fixed dual-energy systems can cost as high as half a million dollars, KA Imaging’s Reveal is highly affordable at less than ¼ of this price.
Any facility can now benefit immediately from higher sensitivity X-ray imaging by simply adding dual energy capability to any installed fixed or portable X-ray machines.
Learn how our technology works.
KA Imaging offers two different models to address your needs. Choose between Capital Purchase with Service or Hardware as a Service. Available in the USA and Canada. Contact us to learn more.
We’re looking for clinical and enterprise partners as we expand. Contact Us to receive more details.
Reveal simultaneously acquires 3 images in one single shot, improving visualization of bone and tissue. Use the slider to transition between a traditional DR and the two dual-energy images created by Reveal.
World Lung Day (WLD) on September 25 is a day of awareness and action for lung health, a chance for all of us to come together and promote improved lung health around the world. Hundreds of millions of people around the world are affected by......
One emerging application for dual-energy X-ray subtraction is the opportunistic detection of coronary calcifications. Coronary artery calcifications (CAC), or the presence of calcium buildups in arteries that supply blood to the heart, is common in patients with coronary heart disease (CHD)3. A 2021 update by the American Heart Association maintains that CHD is the leading cause of death attributable to cardiovascular disease (CVD) in the US. CVD accounted for approximately 18.6......
Showcasing Emerging Technologies for Low-Resource Settings Waterloo, Ont. (September 07, 2021) KA Imaging’s Reveal™ 35C has been included in the World Health Organization’s (WHO) compendium of innovative health technologies for low-resource settings, launched August 31, 2021. This compilation features emerging technologies assessed and found to......
To place an order or request more information, use this form and a KA Imaging representative will contact you within 24 hours.